| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 183 |
| 1 | RITUXIMAB | 182 |
| 2 | METHOTREXATE | 177 |
| 3 | PREDNISONE | 172 |
| 4 | LEFLUNOMIDE | 164 |
| 5 | ACETAMINOPHEN | 162 |
| 6 | ACETAMINOPHEN 500MG | 155 |
| 7 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 155 |
| 8 | PAIN RELIEVER | 155 |
| 9 | TOCILIZUMAB | 154 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | RITUXIMAB AND HYALURONIDASE | 12 | 0.0265 |
| 1 | CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE | 15 | 0.0228 |
| 2 | CAFFEINE CITRATE | 50 | 0.0214 |
| 3 | HYDROCORTISONE BUTYRATE | 35 | 0.0177 |
| 4 | CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL | 5 | 0.0163 |
| 5 | FLUOROMETHOLONE | 47 | 0.0144 |
| 6 | APREPITANT | 99 | 0.0132 |
| 7 | DICLOFENAC POTASSIUM TABLETS | 114 | 0.0131 |
| 8 | NEOMYCIN OINTMENT | 29 | 0.0118 |
| 9 | GOLIMUMAB | 134 | 0.0106 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 194 |
| 1 | Corticosteroid [EPC] | 192 |
| 2 | CD20-directed Cytolytic Antibody [EPC] | 183 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 177 |
| 4 | Antirheumatic Agent [EPC] | 164 |
| 5 | Interleukin-6 Receptor Antagonist [EPC] | 164 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 162 |
| 7 | Vitamin C [EPC] | 159 |
| 8 | Vitamin B12 [EPC] | 150 |
| 9 | Vitamin D [EPC] | 150 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 28 | 0.0407 |
| 1 | Endoglycosidase [EPC] | 62 | 0.0335 |
| 2 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 99 | 0.0114 |
| 3 | Interleukin-17A Antagonist [EPC] | 139 | 0.0037 |
| 4 | Provitamin D2 Compound [EPC] | 102 | 0.0034 |
| 5 | Tetracycline-class Drug [EPC] | 112 | 0.0016 |
| 6 | Antirheumatic Agent [EPC] | 164 | 0.0016 |
| 7 | Histamine-1 Receptor Antagonist [EPC] | 129 | 0.0015 |
| 8 | Aminosalicylate [EPC] | 141 | 0.0014 |
| 9 | Methylxanthine [EPC] | 78 | 0.0013 |